Cipla Limited (BOM:500087)
1,414.95
-1.05 (-0.07%)
At close: Nov 20, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.14 trillion as of November 20, 2026. Its market cap has decreased by 7.31% in one year.
Market Cap
1.14T
Enterprise Value
1.07T
Revenue
279.89B
Global Rank
n/a
Country Rank
n/a
PE Ratio
39.47
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.14T, an increase of 75,420.91%. That is a compound annual growth rate of 24.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.14T | -6.36% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.97T |
| Laurus Labs | 1.24T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 747.32B |
| Alkem Laboratories | 619.94B |